Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of geriatric assessment-guided chemotherapy allocation in elderly advanced non-small cell lung cancer
2008-008372-13Phase 3Completed
- Sponsor
- CHU Rennes
- Start
- Mar 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of carboplatin and docetaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by CHU Rennes. Primary endpoint: Time to treatment failure. Started Mar 2009; status: completed.
02
Drugs
carboplatindocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2008-008372-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008372-13.